Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

IL-8 associates with a pro-angiogenic and mesenchymal subtype in glioblastoma

(2018) Siobhan Conroy et al.   Oncotarget

Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

(2014) M. F. Sanmamed et al.   CLINICAL CANCER RESEARCH

IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis

(2014) L. Skov et al.   JOURNAL OF IMMUNOLOGY

Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis

(2014) Claudia Palena et al.   JNCI-Journal of the National Cancer Institute

Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

(2014) S. L. Highfill et al.   Science Translational Medicine

An Autocrine Loop between TGF- 1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype

(2013) C. Larocca et al.   MOLECULAR CANCER THERAPEUTICS

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies

(2013) B Huang et al.   Cell Death & Disease

Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer

(2012) M. Roselli et al.   CLINICAL CANCER RESEARCH

Influence of IL-8 on the epithelial–mesenchymal transition and the tumor microenvironment

(2012) Claudia Palena et al.   Future Oncology

Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor

(2012) Nannie Bangsgaard et al.   PLoS One

Cancer Vaccines Targeting the Epithelial-Mesenchymal Transition: Tissue Distribution of Brachyury and Other Drivers of the Mesenchymal-Like Phenotype of Carcinomas

(2012) Duane H. Hamilton et al.   SEMINARS IN ONCOLOGY

IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells

(2011) R. I. Fernando et al.   CANCER RESEARCH

Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models

(2010) Yan Ning et al.   INTERNATIONAL JOURNAL OF CANCER

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression

(2009) Chiara Gabellini et al.   EUROPEAN JOURNAL OF CANCER

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation

(2008) A. Seaton et al.   CARCINOGENESIS

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER